To investigate the expression distributions of COL5A1 among different tumor grades, pathological phenotypes, and tumor progression status, the expression profiles and clinical information of gliomas obtained from the CGGA database were integrated and analyzed. This evidence concerns the gene COL5A1 and central nervous system cancer.